Inicio  /  Cancers  /  Vol: 16 Par: 4 (2024)  /  Artículo
ARTÍCULO
TITULO

Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer

Constantin-Dan Tâlvan    
Liviu?a Budi?an    
Elena-Teodora Tâlvan    
Valentin Grecu    
Oana Zanoaga    
Cosmin Mihalache    
Victor Cristea    
Ioana Berindan-Neagoe and Calin Ilie Mohor    

Resumen

This research studied how three types of proteins, called interleukins (namely 8, 17A and 33), are present in the blood of healthy people and people with colon cancer. Colon cancer is a disease that affects the large intestine. The paper looked at 82 people, 42 of whom had colon cancer and 40 of whom did not. The researchers divided the cancer patients into four groups based on how severe their cancer was. The study measured the amount of interleukins in the blood of each person using a special test. The paper analyzed the results of the test, considering the age, gender, and cancer stage of each person. The results showed that younger people, and those with less severe cancer had more interleukins in their blood. The paper also found that two of the interleukins (8 and 17A) were higher in the cancer group, while one of them (33) was higher in the healthy group. The study also found that the interleukins were related to each other in both groups. This research concluded that the interleukins might help detect colon cancer and predict how it will progress. This paper could help improve the diagnosis and treatment of colon cancer.

PÁGINAS
pp. 0 - 0
REVISTAS SIMILARES

 Artículos similares